Research & Reviews: Journal of Pharmaceutics and Nanotechnology

Research & Reviews: Journal of Pharmaceutics and Nanotechnology

Menu

e-ISSN: 2347-7857 p-ISSN: 2347-7849

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Surface-Modified Nanoparticles for Improved Drug Targeting and Reduced Toxicity

Gavin Vaughn*

Department of Chemical and Biomolecular Engineering, University of Tennessee Knoxville, Knoxville, USA

*Corresponding Author:
Gavin Vaughn
Department of Chemical and Biomolecular Engineering, University of Tennessee Knoxville, Knoxville, USA
E-mail: vaughn69@gmail.com

Received: 28-Aug-2024, Manuscript No. JPN-24-150635; Editor assigned: 30-Aug-2024, PreQC No. JPN-24-150635 (PQ); Reviewed: 13-Sep-2024, QC No. JPN-24-150635; Revised: 20-Sep-2024, Manuscript No. JPN-24-150635 (R); Published: 27-Sep-2024, DOI: 10.4172/2347-7857.12.3.010.

Citation: Vaughn G. Surface-Modified Nanoparticles for Improved Drug Targeting and Reduced Toxicity. 2024;12:010.

Copyright: © 2024 Vaughn G. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Research & Reviews: Journal of Pharmaceutics and Nanotechnology

Research & Reviews: Journal of Pharmaceutics and Nanotechnology

Description

Surface modification of nanoparticles is an essential strategy for enhancing drug delivery systems. By altering the surface properties of nanoparticles, researchers can improve drug targeting to specific cells and reduce systemic toxicity.

Targeted delivery: Surface modifications can facilitate the attachment of ligands, antibodies, or peptides that target specific cell types, enhancing drug delivery to diseased tissues [1].

Reduced toxicity: Surface modifications can decrease interactions between nanoparticles and healthy cells, minimizing off-target effects and toxicity.

Improved pharmacokinetics: Modifying the surface of nanoparticles can alter their circulation time in the bloodstream, improving therapeutic efficacy design enables controlled release of drugs over extended periods.

Methods of surface modification

Pegylation: Attaching Poly Ethylene Glycol (PEG) to nanoparticles increases their circulation time and reduces recognition by the immune system [2-6].

Ligand attachment: Conjugating specific ligands (e.g., antibodies) to the surface of nanoparticles allows for targeted delivery to specific cells, such as cancer cells.

Charge modification: Altering the surface charge of nanoparticles can influence their interactions with cells, enhancing cellular uptake.

Applications of surface-modified nanoparticles

Cancer therapy: Surface-modified nanoparticles can deliver chemotherapeutic agents specifically to tumor cells, reducing toxicity to healthy tissues.

Gene therapy: Surface modifications can enhance the delivery of nucleic acids (e.g., siRNA, DNA) to target cells, improving the effectiveness of gene therapies.

Antibiotic delivery: Surface-modified nanoparticles can enhance the delivery of antibiotics to infected tissues, improving treatment outcomes.

Challenges in surface modification

Characterization and quality control: Ensuring consistent and reproducible surface modifications can be challenging.

Regulatory hurdles: The approval process for surface-modified nanoparticles requires thorough evaluation of safety and efficacy [7].

Stability and storage: Surface modifications can impact the stability of nanoparticles, affecting their shelf-life and therapeutic efficacy.

Ongoing research focuses on optimizing surface modifications, exploring new targeting strategies and understanding the mechanisms of drug release from modified nanoparticles [8-11]. Advances in this field hold great promise for enhancing drug delivery systems.

Furthermore, the integration of stimuli-responsive elements into surface-modified nanoparticles can significantly enhance drug delivery efficacy. These nanoparticles can be designed to release their therapeutic payloads in response to specific environmental activates, such as pH changes, temperature fluctuations, or the presence of specific enzymes. This targeted approach ensures that drugs are released precisely where and when needed, minimizing systemic exposure and associated toxicity [12].

Recent advancements in nanotechnology have also enabled the development of multifunctional nanoparticles that combine therapeutic and imaging capabilities. These dual-functioning nanoparticles can provide real-time imaging of drug delivery, allowing for better monitoring of treatment efficacy and enabling clinicians to make informed decisions during therapy [13-15]. By incorporating imaging agents, healthcare providers can visualize the distribution and accumulation of drugs within the target tissues.

Additionally, personalized medicine stands to benefit from the customization of surface-modified nanoparticles. By tailoring nanoparticle properties to the individual patient’s disease profile, treatments can be more effectively matched to patient needs, improving therapeutic outcomes. Collaborative efforts among chemists, biologists and clinicians will be essential to overcome current challenges and translate these innovative drug delivery systems into clinical practice. As research in surface-modified nanoparticles progresses, they hold the potential to revolutionize various therapeutic areas, including oncology, infectious diseases and regenerative medicine.

References